Accelerate Your Knowledge
Access the latest curated, peer-reviewed research and evidence-based resources trusted by universities, colleges, hospitals, corporations, governments, K-12 schools, and public libraries worldwide.
Access the latest curated, peer-reviewed research and evidence-based resources trusted by universities, colleges, hospitals, corporations, governments, K-12 schools, and public libraries worldwide.
Everything you need to know from emerging and advanced research to archives and trusted sources

Consumer Health
Blood cancers, including leukemia, lymphoma, and myeloma, make up nearly 10% of all new cancer diagnoses in the U.S., with the American Cancer Society reporting an estimated 184,720 new cases and 57,670 deaths in 2024, underscoring the urgent need for early detection, improved therapies, and sustained research investment.

Health and Medicine
According to the Centers for Disease Control and Prevention and the American Cancer Society, ovarian cancer is the second most common gynecologic cancer in the U.S., with over 60% of cases diagnosed at stage III or IV and about 20,900 new cases and 12,700 deaths projected in 2025, highlighting the importance of awareness of early symptoms and hereditary risk factors such as BRCA mutations.

Health and Medicine
Prostate cancer is the second most common cancer among American men and the second-leading cause of cancer-related death, with 2025 projections from the American Cancer Society estimating 313,780 new cases and 35,770 deaths; the disease most often affects men over 65, underscoring the value of early detection through PSA screening and DRE when survival prospects are strongest.
Access authoritative research databases that provide highly regarded full-text journals and primary sources across nearly every academic and professional discipline. Access EBSCOhost via your institution.

Academic Search Ultimate offers access to more than 10,000 full-text journals across a wide range of academic disciplines, supporting research across many fields.
Access is provided exclusively via participating institutions.

Designed for business researchers, this database provides users with 3,600+ active full-text journals and trade periodicals, as well as company profiles, country reports, industry reports, business videos, and other sources.
Access is provided exclusively via participating institutions.

With 2,500+ active full-text biomedical and life sciences journals, MEDLINE Ultimate is the most comprehensive collection for medical, biotech, and pharma research worldwide.
Access is provided exclusively via participating institutions.
From breaking discoveries to deep dives, EBSCO has all the information resources to help you push boundaries, drive breakthroughs and make decisions faster.

Changes in woodland cover are expected to have major impacts on social-ecological systems.

Cutting-edge research on privacy protection technologies in biometric systems using advanced machine learning techniques.

Research examines cost behavior impact of industry characteristics on managerial decision making.
For decades, organizations and researchers have relied on our vetted information to guide critical decisions and research. Authority is not a claim, it is our legacy, trusted across industries and time. Whatever the need, one standard remains: information you can trust, sources you can depend on.

EBSCO offers key magazine archives—rich primary sources for research. New titles are added regularly.

EBSCO's Ultimate research databases use linked data to help libraries strengthen information literacy, research skills, and digital learning.
Learn how the Daniel Cosío Villegas Library at the Colegio de México sparked sustainability awareness for libraries across Mexico, with the help of the EBSCO Solar grant.
How Africa Studies Source showcases regional scholarship and serves researchers focused on Africa.
From target selection to regulatory submissions, peer-reviewed literature strengthens every stage of the pipeline. It provides the external validation, benchmarks, and clinical precedent R&D leaders need to reduce risk, accelerate timelines, and make confident decisions.